CatalystEU/UK

Chip, Drug Makers to Drive Non-Residential Construction Rebound, UBS Says

UBS forecasts chip and drug makers driving non-residential construction rebound.

What changed

UBS forecasts chip and drug makers driving non-residential construction rebound.

Why it matters

UBS forecasts chip and drug makers driving non-residential construction rebound. — impact context not separately stored; see What changed.

Sources